Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
56.04B | 55.05B | 49.85B | 42.48B | 47.51B | Gross Profit |
9.73B | 9.94B | 9.77B | 7.54B | 8.33B | EBIT |
227.00M | 1.38B | 2.71B | 1.24B | 1.17B | EBITDA |
4.09B | 4.28B | 5.46B | 3.81B | 1.78B | Net Income Common Stockholders |
342.00M | -257.00M | 2.35B | 1.05B | -1.92B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.28B | 8.29B | 11.52B | 12.75B | 8.06B | Total Assets |
79.12B | 73.03B | 71.49B | 67.91B | 61.86B | Total Debt |
25.58B | 24.88B | 25.06B | 25.64B | 21.40B | Net Debt |
17.30B | 16.59B | 13.54B | 12.89B | 13.33B | Total Liabilities |
42.44B | 40.75B | 40.24B | 38.81B | 34.75B | Stockholders Equity |
31.16B | 26.89B | 26.42B | 22.99B | 20.92B |
Cash Flow | Free Cash Flow | |||
-1.47B | -1.83B | 811.00M | 1.09B | -1.18B | Operating Cash Flow |
2.78B | 2.23B | 4.06B | 3.57B | 2.83B | Investing Cash Flow |
-2.84B | -4.48B | -3.34B | -2.47B | -3.89B | Financing Cash Flow |
-241.00M | -1.38B | -2.12B | 3.80B | 1.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $915.89B | 11.25 | 9.99% | 3.91% | -2.46% | -12.73% | |
73 Outperform | ¥5.16T | 19.41 | 4.70% | 1.63% | 6.57% | 16.16% | |
68 Neutral | $359.35B | 27.97 | 1.72% | 4.22% | -0.38% | -65.61% | |
65 Neutral | ¥9.13B | 6.47 | 3.50% | -3.00% | 88.74% | ||
64 Neutral | $4.27B | 11.81 | 5.31% | 249.66% | 4.08% | -8.61% | |
63 Neutral | ¥8.90B | 17.07 | 3.06% | 1.63% | ― |